Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Model improves accuracy in predicting hair loss effects.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

High BMI worsens hair growth in women with PCOS.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Non-immune factors play a significant role in alopecia areata.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Men with early-onset hair loss have more heart disease risk factors.

Androgenetic alopecia is significantly linked to metabolic syndrome.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hair loss may increase heart disease risk.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.